GLP-1 & BeyondExplore the worldwide timeline →

WPF flagship programsThe Human Peptide Project™The Living Peptide Record™

English

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder | World Peptide Foundation

Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-07 19:54 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4Active, not recruitingINTERVENTIONAL

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

ClinicalTrials.gov · NCT06803888 · Registry updated: 2026-09-03

Condition / research focus: Obesity and Obesity-related Medical Conditions
Sponsor: Ali Aminian
Countries with listed sites: United States
Registry dates and results: Start: 2025-01-29. Completion: 2027-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bariatric Surgery (procedure) — also listed as: Metabolic Surgery, Roux-en-Y Gastric Bypass (RYGB), Sleeve Gastrectomy (SG)
Semaglutide (drug) — also listed as: Ozempic, Wegovy
Tirzepatide (drug) — also listed as: Mounjaro, Zepbound

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Phase 4Active, not recruitingINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

ClinicalTrials.gov · NCT07438444 · Registry updated: 2026-08-21

Condition / research focus: Diabetes Mellitus, Type 2; Obesity; Overweight
Sponsor: Eli Lilly and Company
Countries with listed sites: India
Registry dates and results: Start: 2026-02-27. Completion: 2027-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176

Where the study takes place — 21 listed sites

B. J. Medical College & Civil Hospital
Ahmedabad, India
Site recruitment: Not reported
V.S. General Hospital
Ahmedabad, India
Site recruitment: Not reported
Gujarat Endocrine Center
Ahmedabad, India
Site recruitment: Not reported
Jawahar Lal Nehru Medical College
Ajmer, India
Site recruitment: Not reported
Motilal Nehru Medical College Hospital
Allahābād, India
Site recruitment: Not reported
Lifecare Hospital and Research Centre
Bengaluru, India
Site recruitment: Not reported
AIIMS, Bhubaneshwar
Bhubaneswar, India
Site recruitment: Not reported
Sri Ramachandra MedicaL College & Research Institute
Chennai, India
Site recruitment: Not reported
Kovai Diabetes Speciality Center and Hospital
Coimbatore, India
Site recruitment: Not reported
Apollo Excelcare Hospital
Guwahati, India
Site recruitment: Not reported
Osmania Medical College & Hospital
Hyderabad, India
Site recruitment: Not reported
Eternal Heart Care Center and Research Institute
Jaipur, India
Site recruitment: Not reported
K care Hospital
Kanpur, India
Site recruitment: Not reported
Brij Medical Centre Private Limited
Kanpur, India
Site recruitment: Not reported
ILS Hospitals
Kolkata, India
Site recruitment: Not reported
Government Medical College, Kozhikode
Kozhikode, India
Site recruitment: Not reported
Wockhardt Hospitals
Mumbai, India
Site recruitment: Not reported
Shri Krishna Hrudayalaya & Critical Care Centre
Nagpur, India
Site recruitment: Not reported
Sahyadri Super Speciality Hospital
Pune, India
Site recruitment: Not reported
All India Institute of Medical Sciences
Raipur, India
Site recruitment: Not reported
King George Hospital, Andhra Medical College
Visakhapatnam, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

ClinicalTrials.gov · NCT07202247 · Registry updated: 2026-08-17

Condition / research focus: Prostate Carcinoma; Recurrent Prostate Carcinoma
Sponsor: City of Hope Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2025-11-05. Completion: 2028-04-09 (may be estimated). No results posted in this registry response.

Products and interventions (17)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Antiandrogen Therapy (drug) — also listed as: ADT, Androgen Deprivation Therapy, Androgen Deprivation Therapy (ADT), Anti-androgen Therapy, Anti-androgen Treatment, Antiandrogen Treatment, Hormone Deprivation Therapy, Hormone-Deprivation Therapy
Behavioral Intervention (behavioral) — also listed as: Behavior Conditioning Therapy, Behavior Modification, Behavior or Life Style Modifications, Behavior Therapy, Behavioral, Behavioral Interventions, Behavioral Modification, Behavioral Therapy, Behavioral Treatment, Behavioral Treatments
Biospecimen Collection (procedure) — also listed as: Biological Sample Collection, Biospecimen Collected, Specimen Collection
Cardiac Computerized Tomographic Angiography (procedure)
Computed Tomography (procedure) — also listed as: CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, Diagnostic CAT Scan, Diagnostic CAT Scan Service Type, tomography
Electronic Health Record Review (other)
Internet-Based Intervention (other)
Lifestyle Counseling (behavioral)
Medical Device Usage and Evaluation (other)
Nutritional Intervention (other)
Nutritional Intervention (other)
Questionnaire Administration (other)
Radiation Therapy (radiation) — also listed as: Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation
Referral (other) — also listed as: Referred
Semaglutide (drug) — also listed as: Ozempic, Rybelsus, Wegovy
Short-Term Fasting (other) — also listed as: Intermittent Fasting, Short-term Intermittent Fasting
Tirzepatide (drug)

Where the study takes place — 1 listed sites

City of Hope Medical Center
Duarte, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Worldwide Study Finder

Worldwide Study Finder

Find a study

Registry search results

Bariatric Surgery vs. Semaglutide vs. Tirzepatide

Explore the world’s study registries

Worldwide

Africa

Americas

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin

GLP-1R Actions on Muscle and the Skeleton

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

Incretin Therapies in Obesity-related HFpEF

An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Tirzepatide in MetALD

Comparing Facial Aging Between Identical Twins With 3D Imaging

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Asia

Middle East

Europe

Oceania